RossJC; Richmond Dental Care, Sheffield, UK. Martin A; Public Health Leeds, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Han SP; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
Pokaż więcej
Źródło:
The clinical teacher [Clin Teach] 2023 Feb; Vol. 20 (1), pp. e13551. Date of Electronic Publication: 2022 Nov 06.
Characterization of the cluster MabR prophages of Mycobacterium abscessus and Mycobacterium chelonae.
Autorzy:
Cote J; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA. Welch C; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. Kimble M; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. Archambault D; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. RossJC; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA. Orellana H; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA. Amero K; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. Bourett C; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. Daigle A; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA. Hutchison KW; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA. Molloy SD; Department of Molecular and Biomedical Sciences, University of Maine, Orono, ME 04469, USA.; The Honors College, University of Maine, Orono, ME 04469, USA.
Engaging Youth in Substance Misuse Prevention within State Prevention Systems: Provider Perspectives.
Autorzy:
Ballard PJ; Wake Forest School of Medicine, Department of Family & Community Medicine, Winston-Salem, NC, United States. Hernandez GC; Wake Forest School of Medicine, Winston-Salem, NC, United States. Pankratz MM; Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. RossJC; Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. Wagoner KG; Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. Moore JB; Department of Implementation Science, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. Vidrascu EM; Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Lassiter R; Wake Forest University, Winston-Salem, NC, United States. Daniel J; Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. Rhodes SD; Department of Social Sciences and Health Policy, Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States.
Pokaż więcej
Źródło:
Health behavior and policy review [Health Behav Policy Rev] 2022 Jul; Vol. 9 (4), pp. 933-948. Date of Electronic Publication: 2022 Jul 01.
The role of serial Tc-DPD scintigraphy in monitoring cardiac transthyretin amyloidosis.
Autorzy:
RossJC; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK.; Department of Nuclear Medicine, Barts Health NHS Trust, London, UK. Hutt DF; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Burniston M; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK.; Department of Nuclear Medicine, Barts Health NHS Trust, London, UK. Grigore SF; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Fontana M; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Page J; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK.; Department of Nuclear Medicine, Royal Free London, NHS Foundation Trust, London, UK. Hawkins PN; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Gilbertson JA; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Rowczenio D; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK. Gillmore JD; Division of Medicine (Royal Free Campus), Centre for Amyloidosis and Acute Phase Proteins, London, UK.
Clinician Perspectives on Barriers and Facilitators to Implementing e-Health Technology in Substance Use Disorder (SUD) Treatment Facilities.
Autorzy:
Fleddermann K; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. Molfenter T; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. Jacobson N; Institute for Clinical and Translational Research and School of Nursing, University of Wisconsin-Madison, Madison, WI, USA. Horst J; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. Roosa MR; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. Boss D; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. RossJC; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA. Preuss E; Bureau of Substance Abuse, Iowa Department of Public Health, Des Moines, IA, USA. Gustafson DH; Department of Industrial and Systems Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Pokaż więcej
Źródło:
Substance abuse : research and treatment [Subst Abuse] 2021 Oct 26; Vol. 15, pp. 11782218211053360. Date of Electronic Publication: 2021 Oct 26 (Print Publication: 2021).
Impact of tobacco-pack pictorial warnings on youth and young adults: A systematic review of experimental studies.
Autorzy:
Francis DB; Department of Communication, University of Kentucky, Lexington, United States. Mason N; Manship School of Mass Communication, Louisiana State University, Baton Rouge, United States. RossJC; Department of Social Sciences and Health Policy, Wake Forest School of Medicine, Winston Salem, United States. Noar SM; School of Media & Journalism, University of North Carolina at Chapel Hill, Chapel Hill, United States.; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, United States.
Pokaż więcej
Źródło:
Tobacco induced diseases [Tob Induc Dis] 2019 May 15; Vol. 17, pp. 41. Date of Electronic Publication: 2019 May 15 (Print Publication: 2019).
Does quantification have a role to play in the future of bone SPECT?
Autorzy:
RossJC; Institute of Nuclear Medicine T05, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK. . Vilić D; Radiological Sciences Unit, Imperial College Healthcare NHS Trust, London, UK. Sanderson T; Institute of Nuclear Medicine T05, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK. Vöö S; Institute of Nuclear Medicine T05, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK. Dickson J; Institute of Nuclear Medicine T05, University College London Hospitals NHS Foundation Trust, 235 Euston Road, London, NW1 2BU, UK.; Institute of Nuclear Medicine, University College London, London, UK.
Quantitation of Tc-DPD uptake in patients with transthyretin-related cardiac amyloidosis.
Autorzy:
RossJC; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK.; b Institute of Nuclear Medicine , University College London Hospitals NHS Foundation Trust , London , UK. Hutt DF; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK. Burniston M; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK.; c Nuclear Medicine Department, Nuclear Medicine , Barts Health NHS Trust , London , UK. Page J; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK.; d Nuclear Medicine Department , Royal Free London NHS Foundation Trust , London , UK. Steeden JA; e UCL Centre for Cardiovascular Imaging , University College London , London , UK. Gillmore JD; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK. Wechalekar AD; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK. Hawkins PN; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK. Fontana M; a National Amyloidosis Centre , UCL Medical School (Royal Free Campus) , London , UK.
Extracardiac F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.
Autorzy:
Wagner T; Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London, UK. Page J; National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, NW3 2PF, London, UK. Burniston M; Department of Nuclear Medicine, St Bartholomew's Hospital, Barts Health NHS Trust, West Smithfield, London, UK. Skillen A; Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London, UK. RossJC; National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, NW3 2PF, London, UK. Manwani R; National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, NW3 2PF, London, UK. McCool D; Department of Nuclear Medicine, Royal Free Hospital, Pond Street, London, UK. Hawkins PN; National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, NW3 2PF, London, UK. Wechalekar AD; National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, NW3 2PF, London, UK. .
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies